In The Know-September 2021

September 2021

Pdf Summary

Ed’s List, titled "In The Know: Gyn Onc Literature of Significance," provides a summary of significant findings from various studies and publications in the field of gynecologic oncology. The list covers topics such as ovarian cancer subtypes, predictive molecular markers for chemotherapy, the impact of chemotherapy timing in ovarian cancer, cost-effectiveness analysis for cancer surveillance and prevention, the association between cancer drug pricing and clinical benefit, genomic and epigenomic evolution in cancer ecosystems, increased risk of second primary malignancies in endometrial cancer survivors, neoadjuvant chemotherapy for advanced ovarian cancer, PTEN expression in ovarian cancer, survival endpoints for uterine carcinosarcoma and serous carcinoma, PARP inhibitors and acquired RAD51C promoter methylation loss, a mouse model of HPV-associated carcinoma, Lynch syndrome detection in endometrial and nonserous/nonmucinous ovarian cancer, BRCA1/2 mutations and endometrial cancer risk, and BRCA1/2 mutations and EC risk in women. Tables of contents for Gynecologic Oncology are also provided.

Keywords

Gyn Onc Literature

ovarian cancer subtypes

predictive molecular markers

chemotherapy timing

cost-effectiveness analysis

cancer drug pricing

genomic and epigenomic evolution

second primary malignancies

neoadjuvant chemotherapy

PTEN expression